For instance, MSCs overexpressing CX3CL1 have been shown to attenuate synaptic loss and the levels of pro-inflammatory cytokines in APP/PS1 transgenic AD mice (Li et al., 2020). Here, CX3CL1 is linked to Alzheimer disease.